Advanced Therapy Medicinal Products CDMO Market (By Product: Gene Therapy, Cell Therapy, Tissue Engineered, Others (Combined ATMPs, for example biodegradable matric or scaffold); By Phase: Phase I, Phase II, Phase III, Phase IV; By Indication: Oncology, Cardiology, Central Nervous System, Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology & Inflammation, Ophthalmology, Haematology, Gastroenterology) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

The global Advanced Therapy Medicinal Products CDMO market size is expected to be worth around US$ 20.9 billion by 2030, according to a new report by Vision Research Reports.

The global Advanced Therapy Medicinal Products CDMO market size was valued at US$ 7.29 billion in 2020 and is anticipated to grow at a CAGR of 13.0% during forecast period 2021 to 2030.

Report Coverage

Growth Factors

The growing demand for advanced therapy is the key factor fueling the market growth. The growth is attributed to the increasing prevalence of rare and life-threatening diseases, such as metabolic and optical diseases, and rising investment in R&D of advanced therapy medicinal product. Besides, ATMPs such as mesenchymal stem cells (MSCs) are a new treatment effective against the COVID-19 virus.

The growth of the market is credited to the increasing clinical trials of ATMP and the rising awareness and belief among researchers regarding the benefits of advanced therapy. The COVID-19 pandemic has significantly disrupted the cell and gene therapy industry due to the complexity in the manufacturing process.

By Product Analysis

The gene therapy accounted for the largest revenue share of over 51.0% in 2020. The rapid growth of the segment is attributed to the advancements in therapy as the treatment can alter and improve the genetics or specifically modify the targeted therapeutic treatment.

In the last few years, gene therapy has observed lucrative growth due to the efficiency in invading cells and initiating the genetic materials. The most common method used in gene therapy is recombinant DNA technology. 

By Indication Analysis

Oncology accounted for the largest revenue share of over 46.0% in 2020. The growth of the segment is attributed to the increasing prevalence of cancer and chronic diseases owing to the rising geriatric population. Oncology is a branch of medicines, which diagnoses and treats cancer.

According to the WHO, cancer is the second-largest leading cause of death globally and nearly 10 million people died due to cancer in 2020. Most of the cancer cases have been found in undeveloped nations and it mainly affects the low- or middle-income countries due to the lack of a proper medical system.

By Phase Analysis

Phase III accounted for the largest revenue share of over 51.0% in 2020. The growth of the segment is owing to the fact that phase III trials involve a large number of patients, and this phase is also the most extensive study period as it includes a comparison of the efficiency and safety of the new drug. 

Phase I held the second-largest revenue share in 2020 owing to the growing R&D activities. With the advent of the Covid-19 pandemic and the use of ATMPs in the treatment of infectious diseases, the segment is expected to witness lucrative growth over the next 2-3 years.

By Regional Analysis

North America held the largest revenue share of over 45.0% in 2020 owing to the growing awareness regarding advanced therapy and rising outsourcing activities.

The region has a favorable regulatory environment as the FDA has approved a few gene therapy products for sale in the U.S.  such as ALLOCORD and ABECMA. According to the reports by American Biopharmaceutical Companies.

Key Players

• Celonic

• Bio Elpida

• CGT Catapult

• Rentschler Biopharma SE

• AGC Biologics

• Catalent

• Lonza

• WuXi Advanced Therapies

• BlueReg

• Minaris Regenerative Medicine

• Patheon 

Market Segmentation

• By Product

  • Gene Therapy

  • Cell Therapy

  • Tissue Engineered

  • Others (Combined ATMPs, for example biodegradable matric or scaffold)

• By Phase 

  • Phase I

  • Phase II

  • Phase III

  • Phase IV

• By Indication 

  • Oncology

  • Cardiology

  • Central Nervous System

  • Musculoskeletal

  • Infectious Disease

  • Dermatology

  • Endocrine, Metabolic, Genetic

  • Immunology & Inflammation

  • Ophthalmology

  • Haematology

  • Gastroenterology

  • Others

• Regional

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

    • Chile

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Israel

    • Egypt

The Advanced Therapy Medicinal Products CDMO market research report covers definition, classification, product classification, product Advanced Therapy Medicinal Products CDMO, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Advanced Therapy Medicinal Products CDMO market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and Advanced Therapy Medicinal Products CDMO. Market size and forecast for each Advanced Therapy Medicinal Products CDMO segment have been provided for the global and regional market.

This report focuses on the global Advanced Therapy Medicinal Products CDMO market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Advanced Therapy Medicinal Products CDMO market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Advanced Therapy Medicinal Products CDMO market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Advanced Therapy Medicinal Products CDMO capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Advanced Therapy Medicinal Products CDMO by regions (countries) and Advanced Therapy Medicinal Products CDMO.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Advanced Therapy Medicinal Products CDMO market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Advanced Therapy Medicinal Products CDMO market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Advanced Therapy Medicinal Products CDMO market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main Advanced Therapy Medicinal Products CDMO areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and Advanced Therapy Medicinal Products CDMO. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Advanced Therapy Medicinal Products CDMO industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

Advanced Therapy Medicinal Products CDMO market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, Advanced Therapy Medicinal Products CDMO dominance. The above data points provided are only related to the companies’ focus related to Advanced Therapy Medicinal Products CDMO market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Advanced Therapy Medicinal Products CDMO market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Advanced Therapy Medicinal Products CDMO market. These factors have benefited the growth of the global market for Advanced Therapy Medicinal Products CDMO. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Advanced Therapy Medicinal Products CDMO. The global market is segmented on the basis of region, Advanced Therapy Medicinal Products CDMO, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Advanced Therapy Medicinal Products CDMO are as follows:

• History Year: 2017-2020

• Base Year: 2021

• Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

The study objectives of this report are:

• To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
• Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• To define, describe and forecast the market by type, Advanced Therapy Medicinal Products CDMO and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.